BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 1:19:00 PM | Browse: 1321 | Download: 1028
 |
Received |
|
2012-10-21 14:08 |
|
Peer-Review Started |
|
2012-10-22 11:49 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2012-12-27 17:00 |
|
Revised |
|
2013-01-05 16:20 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-01-18 13:01 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-01-19 01:47 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
2013-02-26 19:31 |
|
Typeset the Manuscript |
|
2013-04-01 19:42 |
|
Publish the Manuscript Online |
|
2013-04-14 19:05 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Autobiography |
| Article Title |
Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kazuhiro Kasai, Akira Ushio, Yukiho Kasai, Kei Sawara, Yasuhiro Miyamoto, Kanta Oikawa, Yasuhiro Takikawa and Kazuyuki Suzuki |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kazuhiro Kasai, MD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, Uchimaru 19-1, Morioka, Iwate 020-8505, Japan. kaz-k@yc4.so-net.ne.jp
|
| Key Words |
Cisplatin; DDPH; Hepatocellular carcinoma; Portal vein tumor thrombosis; Transarterial chemoembolization |
| Core Tip |
|
| Publish Date |
2013-04-14 19:05 |
| Citation |
Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Takikawa Y, Suzuki K. Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma. World J Gastroenterol 2013; 19(14): 2242-2248 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i14/2242.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i14.2242 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
